» Articles » PMID: 33816588

The Isolation and Replication of African Swine Fever Virus in Primary Renal-Derived Swine Macrophages

Overview
Journal Front Vet Sci
Date 2021 Apr 5
PMID 33816588
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

African swine fever virus (ASFV) causes hemorrhagic disease in domestic pigs by replicating mainly in monocyte/macrophage lineages. Various primary cells including pulmonary alveolar macrophages have been used for the propagation of ASFV on this account. However, ethical constraints and consistency problems exist as it is necessary to harvest same phenotype of primary cells in order to continue a study. We suggested renal-derived swine macrophages as a novel primary cell candidate to address these issues. These primary cells proved to be permissive to both cell adapted ASFV and a wild-type ASFV. Compared to the commercial cell line MA-104, the renal-derived macrophages were more suitable to isolate the field virus. The consistent molecular characteristics of the renal-derived macrophages were demonstrated by immunocytochemistry with antibodies against macrophage cell surface markers including CD163, CD172a, and Iba-1. Viral protein p30 and p72 expression in ASFV infected macrophages was confirmed by immunocytochemistry by use of specific monoclonal antibodies. We observed increase of cell-free viral DNA and infectious virus titer in infected cell supernatant in successive days-post-infection. These results demonstrated that primary renal-derived swine macrophages are useful for ASFV isolation and propagation in terms of cell phenotypes, susceptibility to the virus, and virus production.

Citing Articles

Replication Characteristics of African Swine Fever Virus (ASFV) Genotype I E70 and ASFV Genotype II Belgium 2018/1 in Perivenous Macrophages Using Established Vein Explant Model.

Han S, Oh D, Balmelle N, Cay A, Ren X, Droesbeke B Viruses. 2024; 16(10).

PMID: 39459935 PMC: 11512260. DOI: 10.3390/v16101602.


African Local Pig Genetic Resources in the Context of Climate Change Adaptation.

Pius L, Huang S, Wanjala G, Bagi Z, Kusza S Animals (Basel). 2024; 14(16).

PMID: 39199941 PMC: 11350805. DOI: 10.3390/ani14162407.


African Swine Fever Diagnosis in Africa: Challenges and Opportunities.

Penrith M, van Emmenes J, Hakizimana J, Heath L, Kabuuka T, Misinzo G Pathogens. 2024; 13(4).

PMID: 38668251 PMC: 11054189. DOI: 10.3390/pathogens13040296.


CA-CAS-01-A: A Permissive Cell Line for Isolation and Live Attenuated Vaccine Development Against African Swine Fever Virus.

Lee S, Kim Y, Cha J, Chathuranga K, Dodantenna N, Kwon H J Microbiol. 2024; 62(2):125-134.

PMID: 38480615 PMC: 11021262. DOI: 10.1007/s12275-024-00116-1.


Population Structure and Genomic Characterisation of the Ashanti Dwarf Pig of Ghana.

Aryee S, Owusu-Adjei D, Osei-Amponsah R, Skinner B, Amuzu-Aweh E, Ahunu B Animals (Basel). 2024; 14(5).

PMID: 38473177 PMC: 10931351. DOI: 10.3390/ani14050792.


References
1.
de Leon P, Bustos M, Carrascosa A . Laboratory methods to study African swine fever virus. Virus Res. 2012; 173(1):168-79. DOI: 10.1016/j.virusres.2012.09.013. View

2.
Mazur-Panasiuk N, Wozniakowski G, Niemczuk K . The first complete genomic sequences of African swine fever virus isolated in Poland. Sci Rep. 2019; 9(1):4556. PMC: 6418159. DOI: 10.1038/s41598-018-36823-0. View

3.
Gallardo C, Sanchez E, Perez-Nunez D, Nogal M, de Leon P, Carrascosa A . African swine fever virus (ASFV) protection mediated by NH/P68 and NH/P68 recombinant live-attenuated viruses. Vaccine. 2018; 36(19):2694-2704. DOI: 10.1016/j.vaccine.2018.03.040. View

4.
Sanchez-Torres C, Gomez-Puertas P, Gomez-del-Moral M, Alonso F, Escribano J, Ezquerra A . Expression of porcine CD163 on monocytes/macrophages correlates with permissiveness to African swine fever infection. Arch Virol. 2003; 148(12):2307-23. DOI: 10.1007/s00705-003-0188-4. View

5.
Weingartl H, Sabara M, Pasick J, van Moorlehem E, Babiuk L . Continuous porcine cell lines developed from alveolar macrophages: partial characterization and virus susceptibility. J Virol Methods. 2002; 104(2):203-16. PMC: 7119708. DOI: 10.1016/s0166-0934(02)00085-x. View